|
Name |
Dehydroisosulochrin
|
Molecular Formula | C17H14O6 | |
IUPAC Name* |
methyl 8-hydroxy-3-methoxy-6-methyl-9-oxoxanthene-1-carboxylate
|
|
SMILES |
CC1=CC(=C2C(=C1)OC3=CC(=CC(=C3C2=O)C(=O)OC)OC)O
|
|
InChI |
InChI=1S/C17H14O6/c1-8-4-11(18)15-12(5-8)23-13-7-9(21-2)6-10(17(20)22-3)14(13)16(15)19/h4-7,18H,1-3H3
|
|
InChIKey |
FLSZNPRKDAAYOZ-UHFFFAOYSA-N
|
|
Synonyms |
Dehydroisosulochrin; Isosulochrin dehydrate; 0Z737D25TT; Methyl 8-hydroxy-3-methoxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate; 9H-Xanthene-1-carboxylic acid, 8-hydroxy-3-methoxy-6-methyl-9-oxo-, methyl ester; 77282-74-7; UNII-0Z737D25TT; Q27251072
|
|
CAS | 77282-74-7 | |
PubChem CID | 101122392 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 314.29 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 82.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 23 | QED Weighted: | 0.575 |
Caco-2 Permeability: | -4.826 | MDCK Permeability: | 0.00002560 |
Pgp-inhibitor: | 0.052 | Pgp-substrate: | 0.02 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.771 |
Blood-Brain-Barrier Penetration (BBB): | 0.095 | Plasma Protein Binding (PPB): | 83.01% |
Volume Distribution (VD): | 0.777 | Fu: | 11.73% |
CYP1A2-inhibitor: | 0.959 | CYP1A2-substrate: | 0.962 |
CYP2C19-inhibitor: | 0.854 | CYP2C19-substrate: | 0.182 |
CYP2C9-inhibitor: | 0.816 | CYP2C9-substrate: | 0.91 |
CYP2D6-inhibitor: | 0.688 | CYP2D6-substrate: | 0.844 |
CYP3A4-inhibitor: | 0.475 | CYP3A4-substrate: | 0.148 |
Clearance (CL): | 2.871 | Half-life (T1/2): | 0.613 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.131 |
Drug-inuced Liver Injury (DILI): | 0.871 | AMES Toxicity: | 0.389 |
Rat Oral Acute Toxicity: | 0.031 | Maximum Recommended Daily Dose: | 0.747 |
Skin Sensitization: | 0.444 | Carcinogencity: | 0.018 |
Eye Corrosion: | 0.077 | Eye Irritation: | 0.96 |
Respiratory Toxicity: | 0.264 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002462 | 0.783 | D06GCK | 0.347 | ||||
ENC005167 | 0.770 | D0K8KX | 0.309 | ||||
ENC002523 | 0.710 | D04AIT | 0.301 | ||||
ENC002197 | 0.684 | D0G4KG | 0.289 | ||||
ENC002106 | 0.681 | D0G5UB | 0.281 | ||||
ENC003814 | 0.662 | D0B0AX | 0.265 | ||||
ENC003543 | 0.653 | D07MGA | 0.253 | ||||
ENC005168 | 0.634 | D0O6KE | 0.252 | ||||
ENC001749 | 0.618 | D0W7JZ | 0.252 | ||||
ENC001750 | 0.616 | D0FA2O | 0.250 |